The Claim
In adults with elevated LDL-C and PPARG polymorphisms, baseline lipid levels are significantly higher than in non-carriers, and these genetic variants are associated with a dyslipidemic phenotype that may be more responsive to targeted omega-3 intervention.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
People with a specific gene variation and high 'bad' cholesterol tend to have even higher cholesterol levels than others, and their bodies might respond better to omega-3 supplements to help lower it.
See the scientific wording
In adults with elevated LDL-C and PPARG polymorphisms, baseline lipid levels are significantly higher than in non-carriers, suggesting that these genetic variants are associated with a dyslipidemic phenotype that may be more responsive to targeted omega-3 intervention.
What the research says
1 studyPeople with a specific gene variant (PPARG) had much better cholesterol improvements when they took omega-3 fish oil than people without the variant, suggesting their bad cholesterol is more responsive to this treatment.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.